Ligand based structural studies of the CB1 cannabinoid receptor

Journal of Peptide Research

Volumn 60, Issue 6, 2002, Pages 348-356

  Picone, R P ^a   Fournier, D J ^a   Makriyannis, Alexandros ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Affinity label; Classical cannabinoid; Covalent probe; G protein coupled receptor; Structure activity relationships

Indexed keywords

CANNABINOID 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; LIGAND;

ARTICLE; DRUG PURIFICATION; DRUG RECEPTOR BINDING; DRUG TARGETING; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RECEPTOR AFFINITY; SITE DIRECTED MUTAGENESIS; X RAY CRYSTALLOGRAPHY;

AMINO ACIDS; ANIMALS; BINDING SITES; GTP-BINDING PROTEINS; HUMANS; LIGANDS; MOLECULAR PROBES; PHOTOAFFINITY LABELS; PROTEIN BINDING; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROCANNABINOL; TRITIUM;

CANNABIS;

EID: 0036950338     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.2002.21069.x     Document Type: Article

References (54)

1. Muller, G. (2002) Towards 3D structures of G protein-coupled receptors: a multidisciplinary approach. Curr. Med. 7, 861-888.
2. Yeagle, P.L., Danis, C., Choi, G., Alderfer, J.L. & Albert, A.D. (2000) Three dimensional structure of the seventh transmembrane helical domain of the G-protein receptor, rhodopsin. Mol. Vis. 6, 125-131.
3. Chopra, A., Yeagle, P.L., Alderfer, J.A. & Albert, A.D. (2000) Solution structure of the sixth transmembrane helix of the G-protein-coupled receptor, rhodopsin. Biochim. Biophys. Acta 1463, 1-5.
4. Kobilka, B., Gether, U., Seifert, R., Lin, S. & Ghanouni, P. (1999) Characterization of ligand-induced conformational states in the beta 2 adrenergic receptor. J. Recept. Signal Transduct. Res. 19, 293-300.
5. Farrens, D.L., Altenbach, C., Yang, K., Hubbell, W.L. & Khorana, H.G. (1996) Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274, 768-770.
6. Ulfers, A.L., McMurry, J.L., Miller, A., Wang, L., Kendall, D.A. & Mierke, D.F. (2002) Cannabinoid receptor-G protein interactions: G (alphai1)-bound structures of IC3 and a mutant with altered G protein specificity. Protein Sci. 11, 2526-2531.
7. Ulfers, A.L., McMurry, J.L., Kendall, D.A. & Mierke, D.F. (2002) Structure of the third intracellular loop of the human cannabinoid receptor. Biochemistry 41, 11344-11350.
8. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C.A., Motoshima, H., Fox, B.A., Le, T.I., Teller, D.C., Okada, T., Stenkamp, R.E., Yamamoto, M. & Miyano, M. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739-745.
9. Sakmar, T.P. (1998) Rhodopsin: a prototypical G protein-coupled receptor. Prog. Nucl Acid Res. Mol. Biol. 59, 1-34.
10. Pardo, L., Ballesteros, J.A., Osman, R. & Weinstein, H. (1992) On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three-dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors. Proc. Natl Acad. Sci. USA 89, 4009-4012.
11. Devane, W.A., Dysarz, F.A. III, Johnson, M.R., Melvin, L.S. & Howlett, A.C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 605-613.
12. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. & Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
13. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., De Costa, B.R. & Rice, K.C. (1990) Cannabinoid receptor localization in brain. Proc. Natl Acad. Sci. USA 87, 1932-1936.
14. Pertwee, R.G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74, 129-180.
15. Goutopoulos, A. & Makriyannis, A. (2002) From cannabis to cannabinergics, new therapeutic opportunities. Pharmacol. Ther. 95, 103.
16. Palmer, S.L., Khanolkar, A.D. & Makriyannis, A. (2000) Natural and synthetic endocannabinoids and their structure-activity relationships. Curr. Pharm. Des. 6, 1381-1397.
17. Porter, A.C. & Felder, C.C. (2001) The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol. Ther. 90, 45-60.
18. Baker, D., Pryce, G., Croxford, J.L., Brown, P., Pertwee, R.G., Makriyannis, A., Khanolkar, A., Layward, L., Fezza, F. & Di Bisogno, T.V. (2001) Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J. 15, 300-302.
19. Adams, R., Harfenst, M. & Lowe, S (1949) New analogs of tetrahydrocannabinol. J. Am. Chem. Soc. 71, 1624-1628.
20. Melvin, L.S. & Johnson, M.R. (1987) Structure-activity relationships of tricyclic and nonclassical bicyclic cannabinoids. NIDA Res. Monogr. 79, 31-47.
21. Xie, X.Q., Eissenstat, M. & Makriyannis, A. (1995) Common cannabimimetic pharmacophoric requirements between aminoalkyl indoles and classical cannabinoids. Life Sci. 56, 1963-1970.
22. Eissenstat, M.A., Bell, M.R., D'Ambra, T.E., Estep, K.G., Haycock, D.A., Olefirowicz, E.M. & Ward, S.J. (1991) Aminoalkylindoles (AAIs): structurally novel cannabinoidmimetics. NIDA Res. Monogr. 105, 427-428.
23. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
24. Mechoulam, R., Ben Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R. & Compton, D.R. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
25. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Alonso, R., Shire, D., Congy, C., Soubrie, P., Breliere, J.C. & Le Fur, G. (1995) Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56, 1941-1947.
26. Lan, R., Liu, Q., Fan, P., Lin, S., Fernando, S.R., McCallion, D., Pertwee, R. & Makriyannis, A. (1999) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem. 42, 769-776.
27. Reggio, P.H. (1999) Ligand-ligand and ligand-receptor approaches to modeling the cannabinoid CB1 and CB2 receptors: achievements and challenges. Curr. Med. Chem. 6, 665-683.
28. Khanolkar, A.D., Palmer, S.L. & Makriyannis, A. (2000) Molecular probes for the cannabinoid receptors. Chem. Phys. Lipids 108, 37-52.
29. Bramblett, R.D., Panu, A.M., Ballesteros, J.A. & Reggio, P.H. (1995) Construction of a 3D model of the cannabinoid CB1 receptor: determination of helix ends and helix orientation. Life Sci. 56, 1971-1982.
30. Tao, Q., McAllister, S.D., Andreassi, J., Nowell, K.W., Cabral, G.A., Hurst, D.P., Bachtel, K., Ekman, M.C., Reggio, P.H. & Abood, M.E. (1999) Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificity. Mol. Pharmacol. 55, 605-613.
31. Song, Z.H., Slowey, C.A., Hurst, D.P. & Reggio, P.H. (1999) The difference between the CB (1) and CB (2) cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN55212-2 for CB(2). Mol. Pharmacol. 56, 834-840.
32. McAllister, S.D., Tao, Q., Barnett-Norris, J., Buehner, K., Hurst, D.P., Guarnieri, F., Reggio, P.H., Nowell Harmon, K.W., Cabral, G.A. & Abood, M.E. (2002) A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognition. Biochem. Pharmacol. 63, 2121-2136.
33. Barnett-Norris, J., Hurst, D.P., Lynch, D.L., Guarnieri, F., Makriyannis, A. & Reggio, P.H. (2002) Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor. J. Med. Chem. 45, 3649-3659.
34. Matsui, H., Lefkowitz, R.J., Caron, M.G. & Regan, J.W. (1989) Localization of the fourth membrane spanning domain as a ligand binding site in the human platelet alpha 2-adrenergic receptor. Biochemistry 28, 4125-4130.
35. Vaughan, R.A. (1995) Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping. Mol. Pharmacol. 47, 956-964.
36. Vaughan, R.A. & Kuhar, M.J. (1996) Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis. J. Biol. Chem. 271, 21672-21680.
37. Zhu, J., Yin, J., Law, P.Y., Claude, P.A., Rice, K.C., Evans, C.J. & Chen, C., Yu, L. & Liu-Chen, L.Y. (1996) Irreversible binding of cis-(+)-3-methylfentanyl isothiocyanate to the delta opioid receptor and determination of its binding domain. J. Biol. Chem. 271, 1430-1434.
38. Dorman, G. & Prestwich, G.D. (2000) Using photolabile ligands in drug discovery and development. Trends Biotechnol. 18, 64-77.
39. Knowles, J.R. (1972) Photogenterated reagents for biological receptor-site labeling. Meth Enzymol. 5, 155-160.
40. Cavalla, D. & Neff, N.H. (1985) Chemical mechanisms for photoaffinity labeling of receptors. Biochem. Pharmacol. 34, 2821-2826.
41. Leeb-Lundberg, L.M., Dickinson, K.E., Heald, S.L., Wikberg, J.E., DeBernardis, J.F., Winn, M., Arendsen, D.L., Lefkowitz, R.J. & Caron, M.G. (1983) Covalent labeling of the cerebral cortex alpha 1-adrenergic receptor with a new high affinity radioiodinated photoaffinity probe. Biochem. Biophys. Res. Commun. 115, 946-951.
42. Lomasney, J.W., Leeb-Lundberg, L.M., Cotecchia, S., Regan, J.W., DeBernardis, J.F., Caron, M.G. & Lefkowitz, R.J. (1986) Mammalian alpha 1-adrenergic receptor. Purification and characterization of the native receptor ligand binding subunit. J. Biol. Chem. 261, 7710-7716.
43. Portoghese, P.S., El Kouhen, R., Law, P.Y., Loh, H.H. & Le Bourdonnec, B. (2001) Affinity labels as tools for the identification of opioid receptor recognition sites. Farmaco 56, 191-196.
44. Charalambous, A., Yan, G., Houston, D.B., Howlett, A.C., Compton, D.R., Martin, B.R. & Makriyannis, A. (1992) 5′-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. J. Med. Chem. 35, 3076-3079.
45. Papahatjis, D.P., Kourouli, T., Abadji, V., Goutopoulos, A. & Makriyannis, A. (1998) Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1′-substituted delta 8-tetrahydrocannabinols. J. Med. Chem. 41, 1195-1200.
46. Busch-Petersen, J., Hill, W.A., Fan, P., Khanolkar, A., Xie, X.Q., Tius, M.A. & Makriyannis, A. (1996) Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs. J. Med. Chem. 39, 3790-3796.
47. Morse, K.L. (1995) Pharmacologic characterization of irreversible high affinity probes for the cannabinoid receptor. Masters Dissertation. The University of Connecticut.
48. Thomas, B.F., Compton, D.R. & Martin, B.R. (1990) Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency. J. Pharmacol. Exp. Ther. 255, 624-630.
49. Leeb-Lundberg, L.M., Dickinson, K.E., Heald, S.L., Wikberg, J.E., Hagen, P.O., DeBernardis, J.F., Winn, M., Arendsen, D.L., Lefkowitz, R.J. & Caron, M.G. (1984) Photoaffinity labeling of mammalian alpha 1-adrenergic receptors. Identification of the ligand binding subunit with a high affinity radioiodinated probe. J. Biol. Chem. 259, 2579-2587.
50. Morse, K.L., Fournier, D.J., Li, X., Grzybowska, J. & Makriyannis, A. (1995) A novel electrophilic high affinity irreversible probe for the cannabinoid receptor. Life Sci. 56, 1957-1962.
51. Guo, Y., Abadji, V., Morse, K.L., Fournier, D.J., Li, X. & Makriyannis, A. (1994) (-)-11-Hydroxy-7′-isothiocyanato-1′,1′-dimethylheptyl-delta 8-THC: a novel, high-affinity irreversible probe for the cannabinoid receptor in the brain. J. Med. Chem. 37, 3867-3870.
52. Reggio, P.H., Norris, J.E., Ballesteros, J.A., Guarnieri, F. & Hurst, D.P. (2000) The importance of the helix six beta-XX-beta motif to ligand binding and activaiton of the cananbinoid recpetors. 2000 Symposium on the Cannabinoids. International Cannabinoid Research Society, Burlington, VT, USA.
53. Jensen, A.D., Guarnieri, F., Rasmussen, S.G., Asmar, F., Ballesteros, J.A. & Gether, U. (2001) Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling. J. Biol. Chem. 276, 9279-9290.
54. Ballesteros, J.A., Jensen, A.D., Liapakis, G., Rasmussen, S.G., Shi, L., Gether, U. & Javitch, J.A. (2001) Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276, 19171-29177.